Outcomes of Therasphere Radioembolization for Colorectal Metastases

Clinical Colorectal Cancer

Volumn 14, Issue 3, 2015, Pages 146-153

  Abbott, Andrea M ^a   Kim, Richard ^a   Hoffe, Sarah E ^a   Arslan, Bulent ^b   Biebel, Ben ^a   Choi, Junsung ^a   El Haddad, Ghassan ^a   Kis, Bela ^a   Sweeney, Jennifer ^a   Meredith, Kenneth L ^c   Almhanna, Khaldoun ^a   Strosberg, Jonathan ^a   Shibata, David ^a   Fulp, William J ^a   Shridhar, Ravi ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c SARASOTA MEMORIAL HOSPITAL   (United States)

Author keywords

Colon cancer; Liver metastases; Radiation therapy; Regional therapy; Yttrium 90

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BEVACIZUMAB; BILIRUBIN; CAPECITABINE; CARCINOEMBRYONIC ANTIGEN; CETUXIMAB; FLUOROURACIL; IRINOTECAN; MICROSPHERE; OXALIPLATIN; PANITUMUMAB; YTTRIUM 90; ANTINEOPLASTIC AGENT; YTTRIUM;

ABDOMINAL PAIN; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ARTIFICIAL EMBOLISM; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CANCER CHEMOTHERAPY; CANCER PATIENT; COLORECTAL CANCER; DRUG EFFECT; EVALUATION STUDY; FATIGUE; FEMALE; FOLLOW UP; HUMAN; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; NAUSEA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PERSONAL EXPERIENCE; PRIMARY TUMOR; RADIOEMBOLIZATION; RETROSPECTIVE STUDY; SIDE EFFECT; TASK PERFORMANCE; VOMITING; ADVERSE EFFECTS; AGED; ARTIFICIAL EMBOLIZATION; COLORECTAL TUMOR; LIVER NEOPLASMS; MIDDLE AGED; PATHOLOGY; PROCEDURES; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; SECONDARY; SURVIVAL RATE; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; COLORECTAL NEOPLASMS; EMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; YTTRIUM RADIOISOTOPES;

EID: 84938979677     PISSN: 15330028     EISSN: 19380674     Source Type: Journal    
DOI: 10.1016/j.clcc.2015.02.002     Document Type: Article

References (32)

1. R. Siegel, C. Desantis, and A. Jemal Colorectal cancer statistics, 2014 CA Cancer J Clin 64 2014 104 117
2. A.M. Abbott, H.M. Parsons, T.M. Tuttle, and E.H. Jensen Short-term outcomes after combined colon and liver resection for synchronous colon cancer liver metastases: a population study Ann Surg Oncol 20 2013 139 147
3. F.M. Johnston, M.N. Mavros, J.M. Herman, and T.M. Pawlik Local therapies for hepatic metastases J Natl Compr Canc Netw 11 2013 153 160
4. D.S. Wang, J.D. Louie, and D.Y. Sze Intra-arterial therapies for metastatic colorectal cancer Semin Intervent Radiol 30 2013 12 20
5. R.C. Martin 2nd, V. Augenstein, N.P. Reuter, C.R. Scoggins, and K.M. McMasters Simultaneous versus staged resection for synchronous colorectal cancer liver metastases J Am Coll Surg 208 2009 842 850 discussion 850-2
6. S. Lyass, G. Zamir, I. Matot, and et al. Combined colon and hepatic resection for synchronous colorectal liver metastases J Surg Oncol 78 2001 17 21
7. D.J. Robertson, T.A. Stukel, D.J. Gottlieb, J.M. Sutherlan, and E.S. Fisher Survival after hepatic resection of colorectal cancer metastases: a national experience Cancer 115 2009 752 759
8. D.J. Bentrem, R.P. DeMatteo, and L.H. Blumgart Surgical therapy for metastatic disease to the liver Annu Rev Med 56 2005 139 156
9. A. Saxena, L. Bester, L. Shan, and et al. A systematic review on the safety and efficacy of yttrium-90 radioembolization for unresectable, chemorefractory colorectal cancer liver metastases J Cancer Res Clin Oncol 140 2014 537 547
10. M.F. Mulcahy, R.J. Lewandoski, S.M. Ibrahim, and et al. Radioembolization of colorectal hepatic metastases using yttrium-90 microspheres Cancer 115 2009 1849 1858
11. M.A. Vente, M. Wondergem, I. van der Tweel, and et al. Yttrium-90 microsphere radioembolization for the treatment of liver malignancies: a structured meta-analysis Eur Radiol 19 2009 951 959
12. J.I. Bilbao, A. deMartino, E. de Luis, and et al. Biocompatibility, inflammatory response, and recannalization characteristics of nonradioactive resin microspheres: histological findings Cardiovasc Intervent Radiol 32 2009 727 736
13. L.M. Wang, A.R. Jani, E.J. Hill, and R.A. Sharma Anatomical basis and histopathological changes resulting from selective internal radiotherapy for liver metastases J Clin Pathol 66 2013 205 211
14. A.S. Kennedy, C. Nutting, D. Coldwell, J. Gaiser, and C. Drachenberg Pathologic response and microdosimetry of (90)Y microspheres in man: review of four explanted whole livers Int J Radiat Oncol Biol Phys 60 2004 1552 1563
15. A. Riaz, R.J. Lewandowski, L.M. Kulik, and et al. Complications following radioembolization with yttrium-90 microspheres: a comprehensive literature review J Vasc Interv Radiol 20 2009 1121 1130 quiz 1131
16. R. Salem, V. Mazzaferro, and B. Sangro Yttrium 90 radioembolization for the treatment of hepatocellular carcinoma: biological lessons, current challenges, and clinical perspectives Hepatology 58 2013 2188 2197
17. S.C. Wang, L. Bester, J.P. Burnes, and et al. Clinical care and technical recommendations for 90-yttrium microsphere treatment of liver cancer J Med Imaging Radiat Oncol 54 2010 178 187
18. A. Kennedy Radioembolization of hepatic tumors J Gastrointest Oncol 5 2014 178 189
19. M. Cremonesi, M. Ferrari, M. Bartolomei, and et al. Radioembolisation with 90Y-microspheres: dosimetric and radiobiological investigation for multi-cycle treatment Eur J Nucl Med Mol Imaging 35 2008 2088 2096
20. R.J. Lewandowski, K.T. Sato, B. Atassi, and et al. Radioembolization with 90Y microspheres: angiographic and technical considerations Cardiovasc Intervent Radiol 30 2007 571 592
21. US Department of Health and Human Services. Common Terminology Criteria for Adverse Events. Available at: http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE-4.03-2010-06-14-QuickReference-8.5x11.pdf. Accessed August 1, 2014.
22. M. Cosimelli, R. Golfieri, P.P. Cagol, and et al. Multi-centre phase II clinical trial of yttrium-90 resin microspheres alone in unresectable, chemotherapy refractory colorectal liver metastases Br J Cancer 103 2010 324 331
23. A.S. Kennedy, D. Coldwell, C. Nutting, and et al. Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: modern USA experience Int J Radiat Oncol Biol Phys 65 2006 412 425
24. R.J. Lewandowski, K. Memon, M.F. Mulcahy, and et al. Twelve-year experience of radioembolization for colorectal hepatic metastases in 214 patients: survival by era and chemotherapy Eur J Nucl Med Mol Imaging 41 2014 1861 1869
25. T.F. Jakobs, R.T. Hoffmann, K. Dehm, and et al. Hepatic yttrium-90 radioembolization of chemotherapy-refractory colorectal cancer liver metastases J Vasc Interv Radiol 19 2008 1187 1195
26. B. Sangro, B. Gil-Alzugaray, J. Rodriguez, and et al. Liver disease induced by radioembolization of liver tumors: description and possible risk factors Cancer 112 2008 1538 1546
27. B. Gil-Alzugaray, A. Chopitea, M. Inarrairaegui, and et al. Prognostic factors and prevention of radioembolization-induced liver disease Hepatology 57 2013 1078 1087
28. R. Seidensticker, M. Seidensticker, R. Damm, and et al. Hepatic toxicity after radioembolization of the liver using (90)Y-microspheres: sequential lobar versus whole liver approach Cardiovasc Intervent Radiol 35 2012 1109 1118
29. R.A. Sharma, G.A. VanHazel, B. Morgan, and et al. Radioembolization of liver metastases from colorectal cancer using yttrium-90 microspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy J Clin Oncol 25 2007 1099 1106
30. B. Gray, G. Van Hazel, M. Hope, and et al. Randomised trial of SIR-spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer Ann Oncol 12 2001 1711 1720
31. G. Van Hazel, A. Blackwell, J. Anderson, and et al. Randomised phase 2 trial of SIR-spheres plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer J Surg Oncol 88 2004 78 85
32. L. Lim, P. Gibbs, D. Yip, and et al. A prospective evaluation of treatment with selective internal radiation therapy (SIR-spheres) in patients with unresectable liver metastases from colorectal cancer previously treated with 5-FU based chemotherapy BMC Cancer 5 2005 132